ACRV
Acrivon Therapeutics, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$2.13
+3.40%Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- -0.45x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.03x
- Net debt / EBITDA
- 0.50x
Liquidity & coverage
- Current ratio
- 7.99x
- Quick ratio
- 7.99x
- Cash ratio
- 7.86x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $80.0M
Cash & dividend
- FCF / debt
- -30.33x
- Cash flow / debt
- -29.75x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026